Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1968 of 6351
-
New obesity drug combo shows promise in early trial
Disease control CompletedThe study is looking at a new medicine to help people lose weight. In this study participants will either get semaglutide and NNC0165-1875 or semaglutide and a "dummy" medicine (placebo). Which treatment participants get is decided by chance. Participants will get 2 injections pe…
Phase 2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
ICU survivors at risk of brittle bones: new trial tests One-Time fix
Disease control Recruiting nowThe Bone Zone trial is a prospective, multi-centre, double-blind, phase II, randomised controlled trial evaluating the effect of denosumab or zoledronic acid compared to placebo on change in bone mineral density over one year in women aged 50 years or older and men aged 70 years …
Phase 2 • Sponsor: Australian and New Zealand Intensive Care Research Centre • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New screening tool aims to spot suicide risk in kids with autism
Knowledge-focused CompletedBackground: Suicide is the second leading cause of death for young people ages 10-24 years. There is no gold standard for evaluating suicidal thoughts and behaviors in young people with autism spectrum disorder (ASD) or other neurodevelopmental disorders (NDD). Also, youth with …
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Sep 10, 2026 01:00 UTC
-
Lung cancer combo trial halted early: what we know
Disease control Stopped earlyThis study is designed to determine if combining consolidative radiation therapy (RT) using a hypofractionated regimen (hfRT) (2 fractions) for boosting the residual primary lung cancer with adjuvant anti-PD-L1 therapy concurrently is safe and will provide better tumor control lo…
Phase 1/2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Double-Drug attack on rheumatoid arthritis shows promise in new trial
Disease control OngoingAs stated by the European League Against Rheumatism (EULAR) and the Société Française de Rhumatologie (SFR), treatment of patients with rheumatoid arthritis (RA) should target sustained remission or at least low disease activity. However, despite significant advances based on var…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Fewer trips to the hospital? new cervical cancer radiation trial aims to cut treatment time
Disease control OngoingThis study is a randomized controlled trial designed to compare hypofractionated whole pelvic radiotherapy with conventional radiotherapy in patients with cervical cancer undergoing concurrent chemoradiotherapy. Hypofractionated radiotherapy delivers a higher dose per treatment …
Sponsor: Siriraj Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
HIIT bikes may boost brain power in breast cancer patients on chemo
Symptom relief OngoingThe purpose of this research is to determine whether a 16-week high intensity interval training (HIIT) exercise program will improve brain health among women undergoing chemotherapy and also improve cardiovascular (heart) function. The names of the study interventions involved i…
Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
New implant offers hope for back pain sufferers
Disease control CompletedThis study is a prospective, randomized study comparing ReActiv8 Therapy to Optimal Medical Management (OMM).
Sponsor: Mainstay Medical • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug crizanlizumab tested for safety in indian sickle cell patients
Disease control CompletedSickle cell disease (SCD) is a genetic blood disorder. Crizanlizumab is indicated to reduce the frequency of vaso-occlusive crises (VOCs) in patients with SCD aged 16 years and older. The purpose of this local Phase IV study was to evaluate the safety of crizanlizumab specifical…
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can biktarvy help Late-Stage HIV patients catch up?
Disease control CompletedThe efficacy and safety of Biktarvy in Treatment-Naïve Late Presenters with HIV-1 Infection
Phase 4 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could a vibrating throat patch silence chronic cough?
Symptom relief Recruiting nowResearchers will test the effect of non-invasive vibrotactile stimulation of the larynx on symptom severity of unexplained chronic cough.
Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New Immune-Guiding drug shows promise in advanced prostate cancer trial
Disease control OngoingThe purpose of this study is to determine the recommended phase 2 dose(s) (RP2Ds) of JNJ-78278343 in Part 1 (Dose Escalation) and the safety at the RP2Ds in Part 2 (Dose Expansion).
Phase 1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a simple score predict which kids with kawasaki disease need stronger treatment?
Knowledge-focused Recruiting nowKawasaki disease (KD) is currently the leading cause of acquired heart diseases in children in developed countries. Cardiac involvement is the main determinant of the long-term prognosis of these patients, as coronary aneurisms (CAAs) may lead to ischemic heart disease and even s…
Sponsor: Meyer Children's Hospital IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
5,000 volunteers needed to help detect pancreatic cancer sooner
Knowledge-focused Recruiting nowThis study aims to facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal adenocarcinoma (PDAC) and to facilitate the use of state-of-the-art machine learning-based algorithms that utilize databases and images with the purp…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New study checks safety of combined heart valve and aorta graft
Disease control Recruiting nowMulticenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New heart valve procedure shows promise for severe aortic stenosis
Disease control OngoingEvaluation of TAVR using the NAVITOR valve in a Global Investigation.
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Pepper patch takes on Post-Surgery pain in major trial
Symptom relief CompletedThis is an interventional, Phase III, double-blind, randomized, controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of repeated topical application of Qutenza (capsaicin 8% topical system) versus low-dose capsaicin control (capsaicin 0.04% to…
Phase 3 • Sponsor: Averitas Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
New drug could tame lupus skin flares
Disease control OngoingThe purpose of this study is to assess the safety, efficacy, and tolerability of deucravacitinib (BMS-986165) compared with placebo in participants with active discoid and/or subacute cutaneous lupus erythematosus (DLE/SCLE). This study will also assess if deucravacitinib is biol…
Phase 2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 26, 2026 15:30 UTC
-
Spinal stimulation trial hopes to restore movement and bladder control
Symptom relief Recruiting nowNeurological disability caused by traumatic lesions of the spinal cord is a significant challenge for medicine and society. These lesions, leading to sublesional central nervous system dysfunction, include sensorimotor, vesico-sphincter and genito-sexual disorders. To date, there…
Sponsor: Hopital Foch • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New trial tests faster radiation for men with spread prostate cancer
Disease control Recruiting nowWe will investigate whether ultrahypofractionation using stereotactic ablative radiotherapy (SABR) or brachytherapy is as well-tolerated as moderately hypofractionated external beam radiotherapy (EBRT) for treating the prostate in patients with oligometastatic prostate cancer. Se…
Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC